Back to
Fred Alger Management, LLC
RNLXY
8 quarters
Position history for
Fred Alger Management, LLC's holdings in RENALYTIX PLC
No. Fred Alger Management exited its RNLXY (Renalytix) position in Q4 2022. Its Q3 2022 13F listed 307,642 shares worth $394,000. Fred Alger Management first reported RNLXY in Q1 2021 and held it in 7 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$8.7M
Total Shares Change
-337,967
Quarter-by-Quarter History
Other major holders of RNLXY: Gilder Gagnon Howe & Co. LLC